UniHealth H1 EBITDA margin falls to 33.31% as costs rise
Key highlights
- UniHealth reported a 33.31% EBITDA margin in H1 FY27, down from 49.77% in H1 FY26.
- Revenue from operations increased 14.67% to Rs 76.45 crore in H1 FY27.
- The presentation's operating-cost measure increased 48.49% to Rs 57.60 crore in H1 FY27.
- Uganda represented 78.05% of UniHealth's reported H1 FY27 geographical revenue mix.
powered by IRIS

Unihealth Hospitals Limited reported an EBITDA margin of 33.31% in H1 FY27, down from 49.77% in H1 FY26, as its presentation’s operating-cost measure rose 48.49% to Rs 57.60 crore following new hospital and clinic commissioning. Total income increased 11.80% to Rs 77.78 crore in the half year ended September 30, 2026.
Know Unihealth Hospitals inside out
Results, valuation, peers and who's buying, in one view.
Why did UniHealth's H1 FY27 EBITDA margin fall?
UniHealth's EBITDA margin fell because the disclosed rise in costs exceeded growth in total income during the ramp-up of newly commissioned facilities. EBITDA, meaning earnings before interest, tax, depreciation and amortisation, declined to Rs 25.91 crore in H1 FY27 from Rs 34.62 crore in H1 FY26, while total income rose from Rs 69.57 crore to Rs 77.78 crore. The resulting margin was 33.31%, a decline of 16.46 percentage points.
The presentation's key-factors section identifies operating expenditure of Rs 57.60 crore for H1 FY27, versus Rs 38.79 crore in H1 FY26. It links the 48.49% increase to the October 2, 2025 commissioning of a 50-bed UMC Hospital in Navi Mumbai, the February 1, 2026 launch of a 30-bed UMC Hospital in Entebbe, and the September 1, 2026 start of the 200-bed Nashik hospital, as well as clinics in Nansana and Hoima, Uganda.
The profit-and-loss summary separately reports total expenditure of Rs 51.87 crore in H1 FY27, compared with Rs 34.95 crore in H1 FY26, while the presentation does not reconcile that line with its Rs 57.60 crore operating-cost measure. Sequentially, EBITDA increased from Rs 24.20 crore in H2 FY26 to Rs 25.91 crore in H1 FY27, but the margin still moved down from 35.88% as total expenditure rose from Rs 43.25 crore to Rs 51.87 crore.
How did UniHealth's H1 FY27 revenue change?
UniHealth's revenue from operations increased 14.67% to Rs 76.45 crore in H1 FY27 from Rs 66.67 crore a year earlier. Other income declined to Rs 1.33 crore from Rs 2.90 crore, leaving total income at Rs 77.78 crore, up 11.80% from Rs 69.57 crore.
Hospitals represented 94.21% of the H1 FY27 revenue mix reported in the presentation, compared with 2.48% for consultancy services and 1.60% for exports and distribution. Other income represented 1.71% of the reported mix. This identifies hospital operations as the principal operating segment behind the Rs 76.45 crore revenue-from-operations figure.
Uganda accounted for 78.05% of the reported H1 FY27 geographical revenue mix, and India accounted for 18.82%. The revenue-by-geography table separately lists Uganda at Rs 64.27 crore, up from Rs 63.24 crore in H1 FY26, while India rose to Rs 15.50 crore from Rs 8.99 crore. Mauritius increased to Rs 1.32 crore from Rs 0.14 crore, and Tanzania reached Rs 0.48 crore from Rs 0.25 crore; the presentation notes Tanzania's H2 FY26 figure was negative Rs 0.06 crore because of foreign-exchange profit or loss.
Got a follow-up? Ask IRIS
What happened to UniHealth's profit attributable to owners?
UniHealth's profit attributable to owners was Rs 14.22 crore in H1 FY27, down from Rs 15.11 crore in H1 FY26, while the related PAT margin was 18.28% versus 21.72%. The figure improved from Rs 10.72 crore in H2 FY26, when the PAT margin was 15.89%, but remained below the prior first-half result.
Finance cost increased 55.93% to Rs 1.84 crore in H1 FY27 from Rs 1.18 crore a year earlier, and depreciation was Rs 5.72 crore versus Rs 3.85 crore. Consolidated profit after tax was Rs 21.52 crore, compared with Rs 28.63 crore in H1 FY26 and Rs 17.09 crore in H2 FY26. The H1 FY27 tax line was negative Rs 3.29 crore, against a Rs 1.24 crore tax charge in H1 FY26.
The allocation of profit to owners changed after UniHealth completed the acquisition of an additional 49.81% stake in Victoria Hospital Limited, Uganda, on September 2, 2026. The share-swap transaction increased ownership from 50% to 99.81%. The presentation says 50% of Victoria Hospital's profit from April 1 through September 1, 2026 and 99.81% from September 2 through September 30, 2026 were attributed to owners.
What does UniHealth's expansion require next?
UniHealth's disclosed next priority is improving utilisation at recently commissioned capacity while pursuing management's ambition of more than 1,000 commissioned beds across India and Africa. The Nashik facility began patient services with 200 beds, four modular operation theatres and a dedicated robotic-surgery facility. Management said occupancy, patient volumes, service mix, specialty departments and referral networks are the mechanisms it expects could support medium-term margin improvement.
The investment accompanying that capacity build is visible in fixed assets, which rose to Rs 165.54 crore at H1 FY27 from Rs 93.97 crore at FY26. Cash flow from investing was negative Rs 74.45 crore in H1 FY27, while financing cash flow was Rs 52.03 crore and operating cash flow was Rs 23.83 crore. Closing cash and bank balances were Rs 12.17 crore, compared with Rs 10.45 crore at FY26.
Reported total debt reached Rs 28.37 crore at H1 FY27, from Rs 21.31 crore in H2 FY26 and Rs 8.03 crore in H1 FY26. The debt-to-equity ratio was 0.13, compared with 0.11 and 0.04 in those respective periods, while net worth was Rs 216.43 crore. Return on capital employed was 6.76%, below 7.94% in H2 FY26 and 15.56% in H1 FY26.
Conclusion
UniHealth's H1 FY27 figures show revenue growth alongside a lower EBITDA margin as the expense base expanded with the commissioning and ramp-up of new facilities. Revenue from operations rose to Rs 76.45 crore, but EBITDA declined to Rs 25.91 crore and the EBITDA margin fell to 33.31%. The reported mix remains concentrated in hospitals and Uganda, which accounted for 94.21% and 78.05%, respectively.
The next results will show whether utilisation improves at the 200-bed Nashik hospital, Navi Mumbai, Entebbe and the Uganda clinics, as management expects. Management's stated plan to exceed 1,000 commissioned beds across India and Africa has no disclosed deadline, while H1 FY27 investing cash outflow of Rs 74.45 crore and total debt of Rs 28.37 crore leave capacity integration and funding trends as disclosed matters to watch.


